These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31074546)

  • 1. Global access to insulin.
    Holt RIG
    Diabet Med; 2019 Jun; 36(6):663-664. PubMed ID: 31074546
    [No Abstract]   [Full Text] [Related]  

  • 2. A perspective on global access to insulin: a descriptive study of the market, trade flows and prices.
    Beran D; Laing RO; Kaplan W; Knox R; Sharma A; Wirtz VJ; Frye J; Ewen M
    Diabet Med; 2019 Jun; 36(6):726-733. PubMed ID: 30888075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective.
    Beran D; Hirsch IB; Yudkin JS
    Diabetes Care; 2018 Jun; 41(6):1125-1131. PubMed ID: 29784696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infertility, Inequality, and How Lack of Insurance Coverage Compromises Reproductive Autonomy.
    Insogna IG; Ginsburg ES
    AMA J Ethics; 2018 Dec; 20(12):E1152-1159. PubMed ID: 30585578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of biosimilar manufacturers in improving access to insulin globally.
    Perrin C; Ewen M; Beran D
    Lancet Diabetes Endocrinol; 2017 Aug; 5(8):578. PubMed ID: 28629907
    [No Abstract]   [Full Text] [Related]  

  • 6. Universal Health Coverage: Assessing Service Coverage and Financial Protection for All.
    Ataguba JE; Ingabire MG
    Am J Public Health; 2016 Oct; 106(10):1780-1. PubMed ID: 27626350
    [No Abstract]   [Full Text] [Related]  

  • 7. Recalling the universal health coverage vision and equity in the COVID-19 vaccine distribution plan.
    Adejumo OA; Adejumo OA
    Pan Afr Med J; 2021; 39():197. PubMed ID: 34603578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems science for universal health coverage.
    Evans TG; Kieny MP
    Bull World Health Organ; 2017 Jul; 95(7):484. PubMed ID: 28670010
    [No Abstract]   [Full Text] [Related]  

  • 9. Having "Skin in the Game" and Allowing Cross-Border Importation of Drugs to Lower High Prices of Cancer Drugs.
    Kantarjian H; Mathisen MS; Lipton JH
    JAMA Oncol; 2015 Sep; 1(6):729-30. PubMed ID: 26182331
    [No Abstract]   [Full Text] [Related]  

  • 10. Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa.
    Buckely M
    Seton Hall Law Rev; 2011; 41(2):625-69. PubMed ID: 21739760
    [No Abstract]   [Full Text] [Related]  

  • 11. The High Cost of Insulin in the United States: An Urgent Call to Action.
    Rajkumar SV
    Mayo Clin Proc; 2020 Jan; 95(1):22-28. PubMed ID: 31902423
    [No Abstract]   [Full Text] [Related]  

  • 12. Access to medicines versus access to treatment: the case of type 1 diabetes.
    Beran D; McCabe A; Yudkin JS
    Bull World Health Organ; 2008 Aug; 86(8):648-9. PubMed ID: 18797626
    [No Abstract]   [Full Text] [Related]  

  • 13. Universal access: making health systems work for women.
    Ravindran TK
    BMC Public Health; 2012; 12 Suppl 1(Suppl 1):S4. PubMed ID: 22992384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal antibodies worldwide and for all?].
    Hirsch F
    Med Sci (Paris); 2019 Dec; 35(12):1196-1197. PubMed ID: 31903938
    [No Abstract]   [Full Text] [Related]  

  • 15. The unequal scramble for coronavirus vaccines - by the numbers.
    Callaway E
    Nature; 2020 Aug; 584(7822):506-507. PubMed ID: 32839593
    [No Abstract]   [Full Text] [Related]  

  • 16. Profiteering from vaccine inequity: a crime against humanity?
    Hassan F; Yamey G; Abbasi K
    BMJ; 2021 Aug; 374():n2027. PubMed ID: 34400410
    [No Abstract]   [Full Text] [Related]  

  • 17. The cost of prescription drugs: rising concerns over equity, fairness and access to essential care.
    Work DR; Domino ME
    N C Med J; 2003; 64(6):270-4. PubMed ID: 14983614
    [No Abstract]   [Full Text] [Related]  

  • 18. Makers of anticancer drugs are "profiteering," say 100 specialists from around the world.
    Laurance J
    BMJ; 2013 Apr; 346():f2810. PubMed ID: 23633224
    [No Abstract]   [Full Text] [Related]  

  • 19. [An alternative and innovative Research and Development model to ensure access to medicines - Neglected diseases, neglected populations, and biomedical innovation system].
    Pécoul B
    Med Sci (Paris); 2016 Dec; 32(12):1049-1050. PubMed ID: 28044961
    [No Abstract]   [Full Text] [Related]  

  • 20. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.
    Tetteh E
    Res Social Adm Pharm; 2009 Sep; 5(3):286-97. PubMed ID: 19733829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.